C Michael Gibson

发表

Correlates of bleeding events among moderate- to high-risk patients undergoing percutaneous coronary intervention and treated with eptifibatide: observations from the PROTECT-TIMI-30 trial.

Eric Peterson, David A Morrow, David J Cohen, 2006, Journal of the American College of Cardiology.

The VIVA Trial Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis

Brian H Annex, Daniel S Berman, D. Berman, 2003 .

The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.

Robert M Califf, R. Califf, M. Mack, 2005, American heart journal.

Rivaroxaban in patients with a recent acute coronary syndrome.

Paul Burton, Deepak L. Bhatt, Deepak L Bhatt, 2012, The New England journal of medicine.

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study

Antonio Colombo, Mitchell W Krucoff, George Dangas, 2013, The Lancet.

Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium

Marco Valgimigli, Pascal Vranckx, Mitchell W Krucoff, 2011, Circulation.

Excess dosing of antiplatelet and antithrombin agents in the treatment of non-ST-segment elevation acute coronary syndromes.

K. Alexander, L. Newby, W. Gibler, 2005, JAMA.

Moving From Hope to Hard Work in Data Sharing.

C Michael Gibson, 2018, JAMA cardiology.

Predictors of door-to-balloon delay in primary angioplasty.

Gregg W Stone, G. Stone, C. Gibson, 2002, The American journal of cardiology.

Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary Syndromes: Simultaneous Assessment of Troponin I, C-Reactive Protein, and B-Type Natriuretic Peptide

Nader Rifai, Christopher P Cannon, David A Morrow, 2002, Circulation.

Acute detection of ST-elevation myocardial infarction missed on standard 12-Lead ECG with a novel 80-lead real-time digital body surface map: primary results from the multicenter OCCULT MI trial.

W Frank Peacock, Charles B Cairns, Duane Pinto, 2009, Annals of emergency medicine.

Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.

Nader Rifai, Christopher P Cannon, David A Morrow, 2005, Journal of the American College of Cardiology.

Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy

Warren J Manning, Barry J Maron, W. Manning, 2008, Circulation. Heart failure.

Embedding a randomized clinical trial into an ongoing registry infrastructure: unique opportunities for efficiency in design of the Study of Access site For Enhancement of Percutaneous Coronary Intervention for Women (SAFE-PCI for Women).

Mitchell W Krucoff, Kevin J Anstrom, Ron Waksman, 2013, American heart journal.

Angiographic Validation of the American College of Cardiology Foundation–The Society of Thoracic Surgeons Collaboration on the Comparative Effectiveness of Revascularization Strategies Study

Sean M. O'Brien, Eric Peterson, Sean O'Brien, 2014, Circulation. Cardiovascular interventions.

Adjunctive transcutaneous ultrasound with thrombolysis: results of the PLUS (Perfusion by ThromboLytic and UltraSound) trial.

W. Weaver, E. Ohman, R. Siegel, 2010, JACC. Cardiovascular interventions.

Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion.

Albert Schömig, A. Schömig, C. Gibson, 2004, Circulation.

Underutilization of evidence-based medications in acute ST elevation myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 9 Registry.

Christopher P Cannon, E. Antman, E. Braunwald, 2002, Critical pathways in cardiology.